Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Episode 16 April 09, 2025 00:40:32
Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry
Power to the Patients
Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Apr 09 2025 | 00:40:32

/

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health. 

Other Episodes

Episode 5

June 06, 2025 00:39:35
Episode Cover

Backing Breakthroughs in Psychedelics

Dina Burkitbayeva, CEO of Freedom Biosciences, shares how she launched one of the first venture funds focused on mental health innovation. After co-founding PsyMed...

Listen

Episode 4

October 09, 2024 00:38:56
Episode Cover

Why Beckley Psytech is Developing the Next Generation of Psychedelics

In this episode, Brandon Li sits down with Cosmo Feilding-Mellen, CEO of Beckley Psytech, to explore the groundbreaking work Beckley is doing in the...

Listen

Episode

October 03, 2023 00:44:42
Episode Cover

Oncology trial strategy with Deb Kientop, VP Clinical Operations at Deka Biosciences

In today’s healthcare landscape, the term ‘patient-centric’ has been showing up more and more. It emphasizes the importance of considering the patient’s needs, experiences,...

Listen